Robert William Gunning
CIK: 0002148571
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAMS
NewAmsterdam Pharma Co N.V.
Officer
Discretionary Trading P&L
Holdings
About Gunning Robert William
Gunning Robert William (SEC CIK 0002148571) files insider reports with the SEC as Vice President, Controller of NewAmsterdam Pharma Co N.V. (NAMS).
Signal8 holds 2 ownership filings by Gunning Robert William (1 Form 3, 1 Form 4), filed between Aug 14, 2026 and Sep 3, 2026. Those filings report 1 transaction, the latest on Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gunning Robert William's filings is in NAARDEN.
Recent filings by Gunning Robert William
- Sep 1, 2026: Grant or award of NAMS shares (Form 4, code A).
Other insiders filing for NewAmsterdam Pharma Co N.V. (NAMS)
- Kastelein Johannes Jacob Pieter, Chief Scientific Officer
- Davidson Michael H., Chief Executive Officer
- Smither John W, Director
- Kooij Louise Frederika, Chief Accounting Officer
- LANGE LOUIS G, Director
- Somaiya Mayur Ian, Chief Financial Officer